Surgical Science Valuation

SUSRF Stock  USD 12.75  0.00  0.00%   
At this time, the company appears to be fairly valued. Surgical Science Sweden has a current Real Value of $12.39 per share. The regular price of the company is $12.75. Our model measures the value of Surgical Science Sweden from inspecting the company fundamentals such as Current Valuation of 743.09 M, return on equity of 0.0357, and Shares Owned By Insiders of 32.75 % as well as reviewing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
12.75
Please note that Surgical Science's price fluctuation is not too volatile at this time. Calculation of the real value of Surgical Science Sweden is based on 3 months time horizon. Increasing Surgical Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Surgical pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Surgical Science Sweden. Since Surgical Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Surgical Pink Sheet. However, Surgical Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  12.75 Real  12.39 Hype  12.75 Naive  12.66
The real value of Surgical Pink Sheet, also known as its intrinsic value, is the underlying worth of Surgical Science Sweden Company, which is reflected in its stock price. It is based on Surgical Science's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Surgical Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
12.39
Real Value
14.29
Upside
Estimating the potential upside or downside of Surgical Science Sweden helps investors to forecast how Surgical pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Surgical Science more accurately as focusing exclusively on Surgical Science's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
11.5612.4513.34
Details
Hype
Prediction
LowEstimatedHigh
10.8512.7514.65
Details
Naive
Forecast
LowNext ValueHigh
10.7712.6614.56
Details

Surgical Science Total Value Analysis

Surgical Science Sweden is at this time projected to have takeover price of 743.09 M with market capitalization of 833.72 M, debt of 29.42 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Surgical Science fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
743.09 M
833.72 M
29.42 M

Surgical Science Investor Information

About 33.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Surgical Science Sweden had 5:1 split on the 26th of May 2020. Based on the measurements of operating efficiency obtained from Surgical Science's historical financial statements, Surgical Science Sweden is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

Surgical Science Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Surgical Science has an asset utilization ratio of 9.22 percent. This implies that the Company is making $0.0922 for each dollar of assets. An increasing asset utilization means that Surgical Science Sweden is more efficient with each dollar of assets it utilizes for everyday operations.

Surgical Science Ownership Allocation

Surgical Science Sweden shows a total of 50.8 Million outstanding shares. Over half of Surgical Science's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.

Surgical Science Profitability Analysis

The company reported the revenue of 366.78 M. Net Income was 86.25 M with profit before overhead, payroll, taxes, and interest of 265.94 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Surgical Science's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Surgical Science and how it compares across the competition.

About Surgical Science Valuation

The pink sheet valuation mechanism determines Surgical Science's current worth on a weekly basis. Our valuation model uses a comparative analysis of Surgical Science. We calculate exposure to Surgical Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Surgical Science's related companies.
Surgical Science Sweden AB develops and markets virtual reality simulators for evidence-based laparoscopic and endoscopic training. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden. Surgical Science is traded on OTC Exchange in the United States.

8 Steps to conduct Surgical Science's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Surgical Science's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Surgical Science's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Surgical Science's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Surgical Science's revenue streams: Identify Surgical Science's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Surgical Science's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Surgical Science's growth potential: Evaluate Surgical Science's management, business model, and growth potential.
  • Determine Surgical Science's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Surgical Science's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Surgical Science Growth Indicators

Investing in growth stocks can be very risky. If the company such as Surgical Science does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding50.8 M
Quarterly Earnings Growth Y O Y0.75
Forward Price Earnings59.5238
Retained Earnings85.8 M

Complementary Tools for Surgical Pink Sheet analysis

When running Surgical Science's price analysis, check to measure Surgical Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgical Science is operating at the current time. Most of Surgical Science's value examination focuses on studying past and present price action to predict the probability of Surgical Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgical Science's price. Additionally, you may evaluate how the addition of Surgical Science to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing